Resources

Thrombosis News

• Rivaroxaban Tied to Lower Brain Bleed Risk in A-Fib A once daily oral dose of rivaroxaban significantly lowers the risk of intracranial hemorrhage in patients with atrial fibrillation at moderate to high risk of stroke, according to a study presented at the American Heart Association''s International Stroke Conference, held from Feb. 1 to 3 in New Orleans.
• Apixaban more effective than aspirin in reducing stroke recurrence The oral factor Xa inhibitor apixaban was more effective than aspirin in reducing the risks for stroke and systemic embolism in patients with atrial fibrillation who have already experienced a stroke or transient ischemic attack and are unsuitable for warfarin therapy.
• Decision Support Tools Help Optimize Acute PE Detection Implementing evidence-based clinical decision support significantly improves the efficiency of computed tomographic angiography use to detect acute pulmonary embolism for patients presenting to an emergency department, according to a study published in the February issue of Radiology.
• ACE Inhibitors Not Linked to Improved Outcomes After ACS For patients with acute coronary syndrome, prior chronic use of an angiotensin-converting enzyme inhibitor is not independently associated with improved in-hospital outcomes, according to a study published in the Feb. 1 issue of The American Journal of Cardiology.